Patents by Inventor Yael Karov

Yael Karov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10346540
    Abstract: Technologies for natural language request processing include a computing device having a semantic compiler to generate a semantic model based on a corpus of sample requests. The semantic compiler may generate the semantic model by extracting contextual semantic features or processing ontologies. The computing device generates a semantic representation of a natural language request by generating a lattice of candidate alternative representations, assigning a composite weight to each candidate, and finding the best route through the lattice. The composite weight may include semantic weights, phonetic weights, and/or linguistic weights. The semantic representation identifies a user intent and slots associated with the natural language request. The computing device may perform one or more dialog interactions based on the semantic request, including generating a request for additional information or suggesting additional user intents.
    Type: Grant
    Filed: September 5, 2017
    Date of Patent: July 9, 2019
    Assignee: Intel Corporation
    Inventors: Yael Karov, Micha Breakstone, Reshef Shilon, Orgad Keller, Eric Shellef
  • Publication number: 20190010491
    Abstract: Described herein are novel polynucleotides associated with prostate and lung cancer. The polynucleotides are miRNAs and miRNA precursors. Related methods ad compositions that can be used for diagnosis, prognosis, and treatment of those medical conditions are disclosed. Also described herein are methods that can be used to identify modulators of prostate and lung cancer.
    Type: Application
    Filed: January 16, 2018
    Publication date: January 10, 2019
    Applicant: Rosetta Genomics Ltd.
    Inventors: Itzhak Bentwich, Amir Avniel, Yael Karov, Ranit Aharonov
  • Publication number: 20180107652
    Abstract: Technologies for natural language request processing include a computing device having a semantic compiler to generate a semantic model based on a corpus of sample requests. The semantic compiler may generate the semantic model by extracting contextual semantic features or processing ontologies. The computing device generates a semantic representation of a natural language request by generating a lattice of candidate alternative representations, assigning a composite weight to each candidate, and finding the best route through the lattice. The composite weight may include semantic weights, phonetic weights, and/or linguistic weights. The semantic representation identifies a user intent and slots associated with the natural language request. The computing device may perform one or more dialog interactions based on the semantic request, including generating a request for additional information or suggesting additional user intents.
    Type: Application
    Filed: September 5, 2017
    Publication date: April 19, 2018
    Inventors: Yael Karov, Micha Breakstone, Reshef Shilon, Orgad Keller, Eric Shellef
  • Patent number: 9920379
    Abstract: Described herein are polynucleotides associated with prostate and lung cancer. The polynucleotides are miRNAs and miRNA precursors. Related methods and compositions that can be used for diagnosis, prognosis, and treatment of those medical conditions are disclosed. Also described herein are methods that can be used to identify modulators of prostate and lung cancer.
    Type: Grant
    Filed: May 4, 2017
    Date of Patent: March 20, 2018
    Assignee: ROSETTA GENOMICS LTD.
    Inventors: Itzhak Bentwich, Amir Avniel, Yael Karov, Ranit Aharonov
  • Patent number: 9890382
    Abstract: Described herein are polynucleotides associated with prostate and lung cancer. The polynucleotides are miRNAs and miRNA precursors. Related methods and compositions that can be used for diagnosis, prognosis, and treatment of those medical conditions are disclosed. Also described herein are methods that can be used to identify modulators of prostate and lung cancer.
    Type: Grant
    Filed: May 4, 2017
    Date of Patent: February 13, 2018
    Assignee: ROSETTA GENOMICS LTD.
    Inventors: Itzhak Bentwich, Amir Avniel, Yael Karov, Ranit Aharonov
  • Patent number: 9886950
    Abstract: Technologies for automatic domain model generation include a computing device that accesses an n-gram index of a web corpus. The computing device generates a semantic graph of the web corpus for a relevant domain using the n-gram index. The semantic graph includes one or more related entities that are related to a seed entity. The computing device performs similarity discovery to identify and rank contextual synonyms within the domain. The computing device maintains a domain model including intents representing actions in the domain and slots representing parameters of actions or entities in the domain. The computing device performs intent discovery to discover intents and intent patterns by analyzing the web corpus using the semantic graph. The computing device performs slot discovery to discover slots, slot patterns, and slot values by analyzing the web corpus using the semantic graph. Other embodiments are described and claimed.
    Type: Grant
    Filed: September 8, 2014
    Date of Patent: February 6, 2018
    Assignee: Intel Corporation
    Inventors: Yael Karov, Eran Levy, Sari Brosh-Lipstein
  • Patent number: 9798719
    Abstract: Technologies for natural language request processing include a computing device having a semantic compiler to generate a semantic model based on a corpus of sample requests. The semantic compiler may generate the semantic model by extracting contextual semantic features or processing ontologies. The computing device generates a semantic representation of a natural language request by generating a lattice of candidate alternative representations, assigning a composite weight to each candidate, and finding the best route through the lattice. The composite weight may include semantic weights, phonetic weights, and/or linguistic weights. The semantic representation identifies a user intent and slots associated with the natural language request. The computing device may perform one or more dialog interactions based on the semantic request, including generating a request for additional information or suggesting additional user intents.
    Type: Grant
    Filed: October 24, 2016
    Date of Patent: October 24, 2017
    Assignee: Intel Corporation
    Inventors: Yael Karov, Micha Breakstone, Reshef Shilon, Orgad Keller, Eric Shellef
  • Publication number: 20170298447
    Abstract: Described herein are polynucleotides associated with prostate and lung cancer. The polynucleotides are miRNAs and miRNA precursors. Related methods and compositions that can be used for diagnosis, prognosis, and treatment of those medical conditions are disclosed. Also described herein are methods that can be used to identify modulators of prostate and lung cancer.
    Type: Application
    Filed: May 4, 2017
    Publication date: October 19, 2017
    Inventors: Itzhak Bentwich, Amir Avniel, Yael Karov, Ranit Aharonov
  • Patent number: 9772994
    Abstract: Technologies for natural language request processing include a computing device having a semantic compiler to generate a semantic model based on a corpus of sample requests. The semantic compiler may generate the semantic model by extracting contextual semantic features or processing ontologies. The computing device generates a semantic representation of a natural language request by generating a lattice of candidate alternative representations, assigning a composite weight to each candidate, and finding the best route through the lattice. The composite weight may include semantic weights, phonetic weights, and/or linguistic weights. The semantic representation identifies a user intent and slots associated with the natural language request. The computing device may perform one or more dialog interactions based on the semantic request, including generating a request for additional information or suggesting additional user intents.
    Type: Grant
    Filed: July 25, 2014
    Date of Patent: September 26, 2017
    Assignee: Intel Corporation
    Inventors: Yael Karov, Micha Breakstone, Reshef Shilon, Orgad Keller, Eric Shellef
  • Publication number: 20170240894
    Abstract: Described herein are polynucleotides associated with prostate and lung cancer. The polynucleotides are miRNAs and miRNA precursors. Related methods and compositions that can be used for diagnosis, prognosis, and treatment of those medical conditions are disclosed. Also described herein are methods that can be used to identify modulators of prostate and lung cancer.
    Type: Application
    Filed: May 4, 2017
    Publication date: August 24, 2017
    Inventors: Itzhak Bentwich, Amir Avniel, Yael Karov, Ranit Aharonov
  • Publication number: 20170226510
    Abstract: Described herein are novel polynucleotides associated with prostate and lung cancer. The polynucleotides are miRNAs and miRNA precursors. Related methods and compositions that can be used for diagnosis, prognosis, and treatment of those medical conditions are disclosed. Also described herein are methods that can be used to identify modulators of prostate and lung cancer.
    Type: Application
    Filed: April 21, 2017
    Publication date: August 10, 2017
    Inventors: Itzhak Bentwich, Amir Avniel, Yael Karov, Ranit Aharonov
  • Patent number: 9650679
    Abstract: Described herein are polynucleotides associated with prostate and lung cancer. The polynucleotides are miRNAs and miRNA precursors. Related methods and compositions that can be used for diagnosis, prognosis, and treatment of those medical conditions are disclosed. Also described herein are methods that can be used to identify modulators of prostate and lung cancer.
    Type: Grant
    Filed: August 13, 2015
    Date of Patent: May 16, 2017
    Assignee: Rosetta Genomics Ltd.
    Inventors: Itzhak Bentwich, Amir Avniel, Yael Karov, Ranit Aharonov
  • Patent number: 9650680
    Abstract: Described herein are novel polynucleotides associated with prostate and lung cancer. The polynucleotides are miRNAs and miRNA precursors. Related methods and compositions that can be used for diagnosis, prognosis, and treatment of those medical conditions are disclosed. Also described herein are methods that can be used to identify modulators of prostate and lung cancer.
    Type: Grant
    Filed: July 13, 2016
    Date of Patent: May 16, 2017
    Assignee: Rosetta Genomics Ltd.
    Inventors: Itzhak Bentwich, Amir Avniel, Yael Karov, Ranit Aharonov
  • Patent number: 9624556
    Abstract: Described herein are novel polynucleotides associated with viral infections. The polynucleotides are miRNAs and miRNA precursors. Related methods and compositions that can be used for diagnosis, prognosis, and treatment of those medical conditions are disclosed. Also described herein are methods that can be used to identify modulators of viral infections.
    Type: Grant
    Filed: July 13, 2015
    Date of Patent: April 18, 2017
    Assignee: Rosetta Genomics Ltd.
    Inventors: Itzhak Bentwich, Amir Avniel, Yael Karov, Ranit Aharonov
  • Publication number: 20170039181
    Abstract: Technologies for natural language request processing include a computing device having a semantic compiler to generate a semantic model based on a corpus of sample requests. The semantic compiler may generate the semantic model by extracting contextual semantic features or processing ontologies. The computing device generates a semantic representation of a natural language request by generating a lattice of candidate alternative representations, assigning a composite weight to each candidate, and finding the best route through the lattice. The composite weight may include semantic weights, phonetic weights, and/or linguistic weights. The semantic representation identifies a user intent and slots associated with the natural language request. The computing device may perform one or more dialog interactions based on the semantic request, including generating a request for additional information or suggesting additional user intents.
    Type: Application
    Filed: October 24, 2016
    Publication date: February 9, 2017
    Inventors: Yael Karov, Micha Breakstone, Reshef Shilon, Orgad Keller, Eric Shellef
  • Publication number: 20160319363
    Abstract: Described herein are novel polynucleotides associated with prostate and lung cancer. The polynucleotides are miRNAs and miRNA precursors. Related methods and compositions that can be used for diagnosis, prognosis, and treatment of those medical conditions are disclosed. Also described herein are methods that can be used to identify modulators of prostate and lung cancer.
    Type: Application
    Filed: July 13, 2016
    Publication date: November 3, 2016
    Inventors: Itzhak Bentwich, Amir Avniel, Yael Karov, Ranit Aharonov
  • Publication number: 20160047004
    Abstract: Described herein are novel polynucleotides associated with viral infections. The polynucleotides are miRNAs and miRNA precursors. Related methods and compositions that can be used for diagnosis, prognosis, and treatment of those medical conditions are disclosed. Also described herein are methods that can be used to identify modulators of viral infections.
    Type: Application
    Filed: July 13, 2015
    Publication date: February 18, 2016
    Inventors: Itzhak Bentwich, Amir Avniel, Yael Karov, Ranit Aharonov
  • Publication number: 20160046935
    Abstract: Described herein are novel polynucleotides associated with prostate and lung cancer. The polynucleotides are miRNAs and miRNA precursors. Related methods and compositions that can be used for diagnosis, prognosis, and treatment of those medical conditions are disclosed. Also described herein are methods that can be used to identify modulators of prostate and lung cancer.
    Type: Application
    Filed: August 13, 2015
    Publication date: February 18, 2016
    Inventors: Itzhak Bentwich, Amir Avniel, Yael Karov, Ranit Aharonov
  • Publication number: 20160002639
    Abstract: The invention provides isolated viral and human nucleic acids associated with viral infection and various nucleic acid molecules relating thereto or derived therefrom. The nucleic acids are useful for prevention, treatment and diagnosis of viral infections.
    Type: Application
    Filed: July 10, 2015
    Publication date: January 7, 2016
    Inventors: Issac Bentwich, Amir Avniel, Ranit Aharonov, Yael Karov, Yonat Shemer-Avni, Asaf Levy
  • Patent number: 9133453
    Abstract: Described herein are polynucleotides associated with prostate and lung cancer. The polynucleotides are miRNAs and miRNA precursors. Related methods and compositions that can be used for diagnosis, prognosis, and treatment of those medical conditions are disclosed. Also described herein are methods that can be used to identify modulators of prostate and lung cancer.
    Type: Grant
    Filed: May 8, 2013
    Date of Patent: September 15, 2015
    Assignee: Rosetta Genomics Ltd.
    Inventors: Itzhak Bentwich, Amir Avniel, Yael Karov, Ranit Aharonov